Cholesteryl ester transfer protein genetic polymorphisms, HDL cholesterol, and subclinical cardiovascular disease in the Multi-Ethnic Study of Atherosclerosis

Atherosclerosis

Volumn 200, Issue 2, 2008, Pages 359-367

  Tsai, Michael Y ^a   Johnson, Craig ^b   Kao, W H Linda ^c   Sharrett, A Richey ^c   Arends, Valerie L ^a   Kronmal, Richard ^b   Jenny, Nancy Swords ^e   Jacobs Jr , David R ^f,g   Arnett, Donna ^h   O'Leary, Daniel ⁱ   Post, Wendy ^c,d  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^f UNIVERSITY OF MINNESOTA   (United States)

^g UNIVERSITY OF OSLO   (Norway)

^h UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

ⁱ TUFTS MEDICAL CENTER   (United States)

Author keywords

CETP; CVD; HDL; MESA

Indexed keywords

ALANINE; ARGININE; CALCIUM; CHOLESTEROL ESTER TRANSFER PROTEIN; CYSTEINE; GLUTAMINE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; PROLINE;

ADULT; AFRICAN AMERICAN; AGED; ALLELE; ARTERY INTIMA PROLIFERATION; ARTERY MEDIA; ARTICLE; ASIAN AMERICAN; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR DISEASE; CAROTID ARTERY; CETP GENE; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSOCIATION; ECHOGRAPHY; EUROPEAN AMERICAN; FEMALE; GENE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HISPANIC; HUMAN; INTERNAL CAROTID ARTERY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; ALLELES; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASES; CHOLESTEROL ESTER TRANSFER PROTEINS; CHOLESTEROL, HDL; COHORT STUDIES; FEMALE; GENETIC VARIATION; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 52049119248     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2007.12.038     Document Type: Article

References (35)

1. Miller G.J., and Miller N.E. Plasma high-density-lipoprotein concentration and development of ischaemic heart disease. Lancet 1 (1975) 16-19
2. Gordon D., and Rifkind B.M. Current concepts: high density lipoproteins - the clinical implications of recent studies. N Engl J Med 321 (1989) 1311-1315
3. Wilson P.W.F., Abbott R.D., and Castelli W.P. High density lipoprotein cholesterol and mortality: the Framingham Heart Study. Arteriosclerosis 8 (1988) 737-741
4. Genest Jr. J.J., Martin-Munleey S.S., McNamara J.R., et al. Familial lipoprotein disorders in patients with coronary heart disease. Circulation 85 (1992) 2025-2033
5. Tall A.R. Plasma cholesteryl ester transfer protein. J Lipid Res 34 (1993) 1255-1274
6. Nagano M., Yamashita S., Hirano K., et al. Molecular mechanisms of cholesteryl ester transfer protein deficiency in Japanese. J Atheroscler Thromb 11 3 (2004) 110-121
7. Corbex M., Poirier O., Fumeron F., et al. Extensive association analysis between the CETP gene and coronary heart disease phenotypes reveals several putative functional polymorphisms and gene-environment interaction. Genet Epidemiol 19 (2000) 64-80
8. Agerholm-Larsen B., Tybjaerg-Hansen A., Schnohr P., Steffensen R., and Nordestgaard B.G. Common cholesteryl ester transfer protein mutations, decreased HDL cholesterol, and possible decreased risk of ischemic heart disease: The Copenhagen City Heart Study. Circulation 102 (2000) 2197-2203
9. Kakko S., Tamminen M., Paivansalo M., et al. Cholesteryl ester transfer protein gene polymorphisms are associated with carotid atherosclerosis in men. Eur J Clin Invest 30 (2000) 18-25
10. Ordovas J.M., Cupples L.A., Corella D., et al. Association of cholesteryl ester transfer protein-TaqIB polymorphism with variations in lipoprotein subclasses and coronary heart disease risk: the Framingham study. Arterioscler Thromb Vasc Biol 20 (2000) 1323-1329
11. Dachet C., Poirier O., Cambien F., Chapman J., and Rouis M. New functional promoter polymorphism, CETP/-629, in cholesteryl ester transfer protein (CETP) gene related to CETP mass and high density lipoprotein cholesterol levels: role of Sp1/Sp3 in transcriptional regulation. Arterioscler Thromb Vasc Biol 20 (2000) 507-515
12. Brousseau M.E., O'Connor Jr. J.J., Ordovas J.M., et al. Cholesteryl ester transfer protein TaqI B2B2 genotype is associated with higher HDL cholesterol levels and lower risk of coronary heart disease end points in men with HDL deficiency: Veterans Affairs HDL Cholesterol Intervention Trial. Arterioscler Thromb Vasc Biol 22 (2002) 1148-1154
13. Kakko S., Tamminen M., Paivansalo M., et al. Variation at the cholesteryl ester transfer protein gene in relation to plasma high density lipoproteins cholesterol levels and carotid intima-media thickness. Eur J Clin Invest 31 (2001) 593-602
14. Eiriksdottir G., Bolla M.K., Thorsson B., et al. The -629C>A polymorphism in the CETP gene does not explain the association of TaqIB polymorphism with risk and age of myocardial infarction in Icelandic men. Atherosclerosis 159 (2001) 187-192
15. Klerkx A.H., Tanck M.W., Kastelein J.J., et al. Haplotype analysis of the CETP gene: not TaqIB, but the closely linked -629C → A polymorphism and a novel promoter variant are independently associated with CETP concentration. Hum Mol Genet 12 (2003) 111-123
16. Kauma H., Savolainen M.J., Heikkila R., et al. Sex difference in the regulation of plasma high density lipoprotein cholesterol by genetic and environmental factors. Hum Genet 97 (1996) 156-162
17. Liu S., Schmitz C., Stampfer M.J., et al. A prospective study of TaqIB polymorphism in the gene coding for cholesteryl ester transfer protein and risk of myocardial infarction in middle-aged men. Atherosclerosis 161 (2002) 469-474
18. Cuchel M., Wolfe M.L., deLemos A.S., and Reder D.J. The frequency of the cholesteryl ester transfer protein-TaqI B2 allele is lower in African Americans than in Caucasians. Atherosclerosis 163 (2002) 169-174
19. Lu H., Inazu A., Moriyama Y., et al. Haplotype analyses of cholesteryl ester transfer protein gene promoter: a clue to an unsolved mystery of TaqIB polymorphism. J Mol Med 81 (2003) 246-255
20. Bild D.E., Bluemke D.A., Burke G.L., et al. Multi-ethnic study of atherosclerosis: objectives and design. Am J Epidemiol 156 (2002) 871-881
21. Cushman M., Cornell E.S., Howard P.R., Bovill E.G., and Tracy R.P. Laboratory methods and quality assurance in the Cardiovascular Health Study. Clin Chem 41 (1995) 264-270
22. Fumeron F., Betoulle D., Luc G., et al. Alcohol intake modulates the effect of a polymorphism of the cholesteryl ester transfer protein gene on plasma high density lipoprotein and the risk of myocardial infarction. J Clin Invest 96 (1995) 1664-1671
23. Carr J.J., Nelson J.C., Wong N.D., et al. Calcified coronary artery plaque measurement with cardiac CT in population-based studies: standardized protocol of Multi-Ethnic Study of Atherosclerosis (MESA) and Coronary Artery Risk Development in Young Adults (CARDIA) study. Radiology 234 (2005) 35-43
24. Nelson J.C., Kronmal R.A., Carr J.J., et al. Measuring coronary calcium on CT images adjusted for attenuation differences. Radiology 235 (2005) 403-414
25. O'Leary D.H., Polak J.F., Kronmal R.A., et al. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N Engl J Med 340 (1999) 14-22
26. Tall A.R., Yvan-Charvet L., and Wang N. The failure of torcetrapib: was it the molecule or the mechanism?. Arterioscler Thromb Vasc Biol 27 (2007) 257-260
27. RADIANCE 1 Investigators. Effect of torcetrapib on carotid atherosclerosis in familial hypercholesterolemia. N Engl J Med 356 (2007) 1620-1630
28. Tai E.S., Ordovas J.M., Corella D., et al. The TaqIB and -629C>A polymorphisms at the cholesteryl ester transfer protein locus: associations with lipid levels in a multiethnic population. The 1998 Singapore National Health Survey. Clin Genet 63 (2003) 19-30
29. Humphries S.E., Berglund L., Isasi C.R., et al. Loci for CETP, LPL, LIPC, and APOC3 affect plasma lipoprotein size and sub-population distribution in Hispanic and non-Hispanic white subjects: the Columbia University BioMarkers Study. Nutr Metab Cardiovasc Dis 12 (2002) 163-172
30. Dobs A.S., Nieto F.J., Szklo M., et al. Risk factors for popliteal and carotid wall thicknesses in the Atherosclerosis Risk in Communities (ARIC) Study. Am J Epidemiol 150 (1999) 1055-1067
31. Zanchetti A., Bond M.G., Hennig M., et al. Risk factors associated with alterations in carotid intima-media thickness in hypertension: baseline data from the European Lacidipine Study on Atherosclerosis. J Hypertens 16 (1998) 949-961
32. Colhoun H.M., Scheek L.M., Rubens M.B., et al. Lipid transfer protein activities in type 1 diabetic patients without renal failure and nondiabetic control subjects and their association with coronary artery calcification. Diabetes 50 (2001) 652-659
33. Benton J.L., Ding J., Tsai M.Y., et al. Associations between two common polymorphisms in the ABCA1 gene and subclinical atherosclerosis: Multi-Ethnic Study of Atherosclerosis (MESA). Atherosclerosis 193 (2007) 352-360
34. Lewis G.F., and Rader D.J. New insights into the regulation of HDL metabolism and reverse cholesterol transport. Circ Res 96 (2005) 1221-1232
35. Tanigawa H., Billheimer J.T., Tohyama J., et al. Expression of cholesteryl ester transfer protein in mice promotes macrophage reverse cholesterol transport. Circulation 116 (2007) 1267-1273